Catalyst Wire Dossier Catalyst Wire Dossier

LL2IgG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LL2IgG, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Humanized LL2IGG to Treat Systemic Lupus Erythematosus [Phase 1]

See pricing